| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |